|
|
|
|
||
Re: Morgan Stanley Highlights-----Pimavanserin, the new ViagraSerendipity! "Big disappointment in SSRI therapy in depression is sexual dysfunction. In Nuplazid phase 2 trial, improvement was seen in sexual function. CEO: what was seen in depression trial in efficacy is exactly what many physicians say they want in new therapies." |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
15621 | Re: Morgan Stanley Highlights-----Pimavanserin, the new Viagra | Biotech2050 | 1 | 9/12/2019 1:37:17 AM |